Bayer aims to comprehensively restructure its pharmaceutical R&D and consumer health operations, a long-awaited move that the company says will refocus assets to its core life science businesses over the coming years. Reports from the past year, including local German media that had suggested up to 1,000 jobs were on the chopping block, were not far off the mark: The final decision includes the loss of about 900 of its 8,000 R&D positions, out of a total reduction of 12,000 jobs across t...
READ MORE
|
Oregon Health & Science University (OHSU) held the first-ever gene therapy clinical trial, BRILLIANCE, to address blindness-causing gene mutation, LCA10, according to a recent press release The clinical trial, sponsored by Allergan plc and Editas Medicine, is one of 14 different clinical trials investigating new genetic treatments for ophthalmic conditions and nearly 50 vision-related clinical trials. The procedure uses gene-editing tool CRISPR to edit human genes, also known as in vivo gene...
READ MORE
|
Athenex, Inc. a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer, today announced the launch of Terbutaline Sulfate Injection, the first product launch by Athenex Pharmaceutical Division (APD) through their joint venture with SunGen Pharma LLC – Athenex Pharmaceuticals....
READ MORE
|
Shares of Rockville, Md.-based MacroGenics, Inc. have skyrocketed nearly 160 percent in premarket trading after the company announced its Phase III HER2-positive metastatic breast cancer study hit the mark. Investors snapping up shares of MacroGenics drove the stock up more than $17 per share. MacroGenics closed at $11.11 per share on Tuesday, but this morning, the stock has jumped to $28.88 per share in premarket trading.
MacroGenics said its clinical asset margetuximab met the primary e...
READ MORE
|
PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, today discussed the comparator arm for its upcoming clinical trial and provided additional clarification on its recent pre-IND meeting with the U.S. Food and Drug Administration (FDA) regarding its upcoming clinical trial in locally advanced, inoperable pancreatic cancer (LAPC)....
READ MORE
|
The frenzied hunt for drugs to ease Covid-19 could make it more difficult for scientists to find lasting treatments. Pharmaceutical-research experts are raising concerns that attempts to offer desperate coronavirus patients some form of treatment may hobble crucial studies of which drugs actually work and which ones don't. More than 100 off-the-shelf and experimental therapies are being tested either formally or informally for the coronavirus disease, including hydroxychloroquine, the antima...
BLOOMBERG
READ MORE
|